Serum peroxiredoxin 3 is reduced in genetic carriers of Parkinson's disease.

Ng, Adeline Sl; Tan, Jayne; Ng, E; Tay, Kay Yaw; Au, Wing Lok; Tan, Louis Cs; Tan, Eng King

Ng, Adeline Sl; Tan, Jayne; Ng, E; Tay, Kay Yaw; Au, Wing Lok; Tan, Louis Cs; Tan, Eng King.

Afiliação

Ng AS; Department of Neurology, National Neuroscience Institute, Singapore adeline.ng.s.l@singhealth.com.sg tan.eng.king@singhealth.com.sg.
Tan J; Neuroscience and Behavioural Disorders Program, Duke-NUS Medical School, Singapore.
Ng E; Department of Neurology, National Neuroscience Institute, Singapore.
Tay KY; Department of Neurology, National Neuroscience Institute - Singapore General Hospital, Singapore.
Au WL; Department of Neurology, National Neuroscience Institute, Singapore.
Tan LC; Department of Neurology, National Neuroscience Institute, Singapore.
Tan EK; Department of Neurology, National Neuroscience Institute, Singapore.

J Neurol Neurosurg Psychiatry ; 94(3): 250-251, 2023 03.

Article em En | MEDLINE | ID: mdl-36171102

Assuntos

Doença de Parkinson; Humanos; Doença de Parkinson/genética; Heterozigoto; Peroxirredoxina III/genética; Mutação; Glucosilceramidase/genética; Predisposição Genética para Doença

Palavras-chave

Parkinson's disease

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson Idioma: En Ano de publicação: 2023 Tipo de documento: Article